GGrantIndex
← Leaderboards

Lian Li

University Of North Carolina Chapel Hill

$19,464,828
Attributed
$21,417,720
Total exposure
15
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,417,720 · 15

By mechanism

R01$15,622,417 · 11
RF1$3,232,393 · 1
R56$2,132,535 · 2
R21$430,375 · 1

Top collaborators

Most similar at University Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposPathogenesisProteinsLinkCellsMolecularInsightBiologicalMutationBrainMediatingSignal TransductionNeurodegenerative DisordersProteomicsParkinson DiseaseBiochemicalRegulationPathway InteractionsHuman DiseaseS DiseaseNerve DegenerationEnzymesEffective TherapyOxidative Stress

Grant awards (52)

Sialoglycoproteomic network and target discovery for Alzheimer's disease$743,785
R01 · FY2025 · AG · contact PI
Sialoglycoproteomic network and target discovery for Alzheimer's disease$769,621
R01 · FY2024 · AG · contact PI
Molecular analysis of SORL1 function and dysfunction in Alzheimer's disease$234,750
R21 · FY2024 · AG · contact PI
Sialoglycoproteomic network and target discovery for Alzheimer's disease$783,746
R01 · FY2023 · AG · contact PI
Molecular analysis of SORL1 function and dysfunction in Alzheimer's disease$195,625
R21 · FY2023 · AG · contact PI
Novel Insights into Ischemic-Induced Cardiac Remodeling$478,647
R01 · FY2021 · HL
Lewy body dementia pathway and biomarker discovery$667,958
R56 · FY2020 · AG
Novel Insights into Ischemic-Induced Cardiac Remodeling$496,372
R01 · FY2020 · HL
Lewy body dementia pathway and biomarker discovery$681,902
R56 · FY2019 · AG
Novel Insights into Ischemic-Induced Cardiac Remodeling$390,000
R01 · FY2019 · HL
SIMPLE-regulated trafficking and peripheral neuropathy$332,748
R01 · FY2019 · NS · contact PI
Novel Insights into Ischemic-Induced Cardiac Remodeling$18,230
R01 · FY2019 · HL
ALZHEIMER'S DISEASE PATHWAYS AND BIOMARKER DISCOVERY BY INTEGRATIVE PROTEOMICS, GLYCOPROTEOMICS, AND GLYCOMICS$3,232,393
RF1 · FY2018 · AG · contact PI
Innovative Glycomic/Glycoproteomic Investigation on Alzheimer’s Disease$782,675
R56 · FY2018 · AG
Novel Insights into Ischemic-Induced Cardiac Remodeling$390,000
R01 · FY2018 · HL
SIMPLE-regulated trafficking and peripheral neuropathy$332,748
R01 · FY2018 · NS · contact PI
SIMPLE-regulated trafficking and peripheral neuropathy$332,748
R01 · FY2017 · NS · contact PI
SIMPLE-regulated trafficking and peripheral neuropathy$332,748
R01 · FY2016 · NS · contact PI
Function and mechanism of a novel SUMO protease$296,400
R01 · FY2016 · GM · contact PI
SIMPLE-regulated trafficking and peripheral neuropathy$332,748
R01 · FY2015 · NS · contact PI
Function and mechanism of a novel SUMO protease$296,400
R01 · FY2015 · GM · contact PI
Function and mechanism of a novel SUMO protease$296,400
R01 · FY2014 · GM · contact PI
Function and mechanism of a novel SUMO protease$296,400
R01 · FY2013 · GM · contact PI
Pathogenic Mechanisms of Environmental Toxicants in Parkinson's Disease$341,811
R01 · FY2012 · ES · contact PI
Pathogenic Mechanisms of Environmental Toxicants in Parkinson's Disease$341,811
R01 · FY2011 · ES · contact PI
The PINK1 Mitochondrial Signaling Pathway$288,639
R01 · FY2011 · GM · contact PI
Pathogenic Mechanisms of Environmental Toxicants in Parkinson's Disease$345,263
R01 · FY2010 · ES · contact PI
The PINK1 Mitochondrial Signaling Pathway$291,555
R01 · FY2010 · GM · contact PI
Pathogenic Mechanisms of Environmental Toxicants in Parkinson's Disease$348,750
R01 · FY2009 · ES · contact PI
The PINK1 Mitochondrial Signaling Pathway$294,500
R01 · FY2009 · GM · contact PI
The PINK1 Mitochondrial Signaling Pathway$273,352
R01 · FY2009 · GM · contact PI
Pathogenic Mechanisms of Environmental Toxicants in Parkinson's Disease$348,375
R01 · FY2008 · ES · contact PI
Characterization of a neuronal ubiquitination machinery$335,479
R01 · FY2008 · NS · contact PI
The PINK1 Mitochondrial Signaling Pathway$294,342
R01 · FY2008 · GM · contact PI
Characterization of a neuronal ubiquitination machinery$335,479
R01 · FY2007 · NS · contact PI
Ubiquitin-mediated proteolysis at synaptic terminals$324,277
R01 · FY2007 · AG · contact PI
Mechanisms of Endosome-to-Lysosome Trafficking in Brain$268,383
R01 · FY2007 · NS · contact PI
Characterization of a neuronal ubiquitination machinery$345,498
R01 · FY2006 · NS · contact PI
Ubiquitin-mediated proteolysis at synaptic terminals$333,963
R01 · FY2006 · AG · contact PI
Mechanisms of Endosome-to-Lysosome Trafficking in Brain$276,399
R01 · FY2006 · NS · contact PI
Characterization of a neuronal ubiquitination machinery$353,813
R01 · FY2005 · NS
Ubiquitin-mediated proteolysis at synaptic terminals$342,000
R01 · FY2005 · AG
Mechanisms of Endosome-to-Lysosome Trafficking in Brain$283,050
R01 · FY2005 · NS
Characterization of a neuronal ubiquitination machinery$353,813
R01 · FY2004 · NS
Ubiquitin-mediated proteolysis at synaptic terminals$342,000
R01 · FY2004 · AG
Mechanisms of Endosome-to-Lysosome Trafficking in Brain$283,050
R01 · FY2004 · NS
Ubiquitin-mediated proteolysis at synaptic terminals$342,000
R01 · FY2003 · AG
MOLECULAR GENETIC ANALYSIS OF SYNAPTIC TRANSMISSION$203,371
R01 · FY2002 · NS
NOVEL PROTEINS IN NEUROTRANSMITTER RELEASE$222,332
R01 · FY2001 · NS
MOLECULAR GENETIC ANALYSIS OF SYNAPTIC TRANSMISSION$187,708
R01 · FY2001 · NS
NOVEL PROTEINS IN NEUROTRANSMITTER RELEASE$212,772
R01 · FY2000 · NS
MOLECULAR GENETIC ANALYSIS OF SYNAPTIC TRANSMISSION$188,891
R01 · FY2000 · NS